Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...
The Office of the UN High Commissioner for Refugees provides protection and material assistance to refugees and other people in many parts of the world, often under emergency situations. UNHCR invites ...